SRI and QED-C to leverage team of industry, national lab and academic
partners to develop roadmap
Press releases
SRI Ventures announces new spin-out, Confidencial, to secure sensitive information and collaboration for distributed enterprises
Confidencial secures seed funding to add privacy-preserving cryptographic tech to existing business applications
SRI International announces investment in Prevasio
Security administrators can now secure cloud infrastructure with SRI AI technology
SRI awarded $23 million contract for education research partnerships across Kentucky, Tennessee, Virginia and West Virginia
MENLO PARK, Calif.—January 13, 2022— SRI Education has been awarded a new, five-year, $23 million dollar contract from the Institute of Education Sciences of the U.S. Department of Education to fund the continued leadership of the Regional Educational Laboratory (REL) Appalachia through 2026. SRI has led REL Appalachia since 2017 and will continue to partner […]
SRI International announces collaboration agreement with Janssen
Collaboration focuses on SRI’s Synfini artificial intelligence and automation platform to accelerate small-molecule drug discovery
Nomura-SRI Innovation Center welcomes new members and plans to increase membership in 2022
MENLO PARK, Calif., December 16, 2021, The Nomura-SRI innovation center (NSIC) announced today that they will be welcoming several major member additions including Asahi Quality & Innovations, Ltd (Independent Research subsidiary of Asahi Group Holdings, Ltd.), and Showa Denko K.K. The new members join an existing diverse and motivated set of charter members from Japanese […]
SRI Bioscience awarded $14.7 million contract to continue development of high-concentration Naloxone formulation
MENLO PARK, CA (December 8, 2021)— SRI Biosciences has been awarded a $14.7 million contract sponsored by the Defense Threat Reduction Agency (DTRA) through the Medical, Chemical, Biological, Radiological, and Nuclear Defense Consortium (MCDC) to continue development of a high-concentration naloxone product for intravenous, intramuscular and subcutaneous injection, or intravenous infusion. Under the three-year contract, […]
SRI International names Dr. David E. Parekh as CEO
MENLO PARK, CA (October 26, 2021) – SRI International announced today that its Board of Directors has appointed Dr. David E. Parekh as CEO, effective December 1st, 2021. David Parekh has had a storied career in technology research and development, most recently as an independent consultant as well as serving on various boards, including those […]
SRI spinout Wingsure develops AI-driven mobile insurance app for small farmers
Underserved farmers can now insure crops with rapid claim resolution through mobile phones using the Wingsure app
